ReviewTargeted oncology2015

Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology.

Sohita DhillonPubMed ↗Publisher ↗

No numbers read from the abstract.